id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-P-2236-0003,FDA,FDA-2020-P-2236,Response Letter from FDA CDER to Covington & Burling LLP,Other,Response(s),2021-05-24T04:00:00Z,2021,5,2021-05-24T04:00:00Z,,2021-05-24T14:41:33Z,,0,0,0900006484b2edd0